MedTrace Logo

Intraocular Steroid After Cataract Surgery Study

NCT00478764 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2007-05-25

No results posted yet for this study

Summary

The use of one dose of an antibiotic and steroid injected into the eye at the end of cataract surgery is as safe and effective as the post operative use of eyedrops after cataract surgery.

Conditions

  • Cataract

Interventions

DRUG

intraocular triamcinolone and gatifloxicin

Sponsors & Collaborators

  • Dean Health System

    lead OTHER

Principal Investigators

  • Jonathan G Stock, MD · Dean Health Systems

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-03-31
Completion
2007-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00478764 on ClinicalTrials.gov